Intelligent GxP Manufacturing with Aizon

CEO, CTO, Co-Founder

Aizon

Jun 10, 2025PAO-04-24-PHEX-17

Artificial Intelligence Data PA TV (video)

Aizon is leading the shift toward intelligent GxP Manufacturing. Their AI-powered software delivers predictive insights that improve yield, minimize deviations, and ensure product quality in pharmaceutical manufacturing.

From Screening to Design: Can Production Cell Lines Become Programmable Platforms?

David Alvaro, Ph.D.

Pharma's Almanac

PAO-06-26-PA-19Jul 20, 2026

Preclinical R&D

How Much of Your Last Year’s Research Budget Felt Wasted? The Hidden Cost of Experimental Inconsistencies

Sophie Lutter, Ph.D.; Andrew Chalmers, Ph.D.

Lab Thread

PAO-06-26-CL-05Jun 29, 2026

Gender Bias AI

Testing and Correcting Gender Bias in Healthcare AI

David Alvaro, Ph.D.

Pharma's Almanac

PAO-06-26-PA-21Jun 24, 2026

Data Integrity

Data Integrity: Drivers, Challenges, and Key Program Elements

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-06-26-PA-20Jun 23, 2026

CRO Partnerships

Building Resilient Development Models: How Mid-Size Pharma Can Scale Without Losing Control

Brian Healey

IQVIA

PAO-06-26-CL-02Jun 17, 2026

CNS Clinical

Insilico Completes First-in-Human Dosing in Phase I Clinical Study of AI-Driven NLRP3 Inhibitor ISM8969

Insilico Medicine

PR-06-26-01Jun 17, 2026

Clinical Evidence

Rethinking Clinical Evidence Requirements in Rare Diseases

David Alvaro, Ph.D.

Pharma's Almanac

PAO-06-26-PA-09Jun 16, 2026

Digital Sampling

Enhancing Quality and Environmental Monitoring Efficiency Through Paperless Sampling

Jiwoon Kim; Neulbit Kim; Hyeonjung Park

Samsung Biologics

PAO-06-26-CL-01Jun 10, 2026

Protein Engineering

Exponential Advances in Protein Engineering

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-06-26-PA-04Jun 8, 2026

AI in Manufacturing

Validating and Governing AI in GMP Manufacturing

Pharma's Almanac

PAO-06-26-PA-03Jun 4, 2026

AI Data Integrity

Data Integrity in the Age of AI-Assisted Manufacturing

Pharma's Almanac

PAO-06-26-PA-02Jun 3, 2026

Partnership

The Solubility Company and Persist AI Unveil Strategic Partnership to Bridge the Data Gap in AI-Driven Drug Formulation

The Solubility Company

PR-05-26-02May 13, 2026

Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us Nice Insight That's Nice

Reach Our Team

My Account

Subscribe for the newsletter

Subscribe for the Newsletter

Mobile Navigation

Intelligent GxP Manufacturing with Aizon

Related Content

AI-Optimized CLD

From Screening to Design: Can Production Cell Lines Become Programmable Platforms?

David Alvaro, Ph.D.

Pharma's Almanac

Preclinical R&D

How Much of Your Last Year’s Research Budget Felt Wasted? The Hidden Cost of Experimental Inconsistencies

Sophie Lutter, Ph.D.; Andrew Chalmers, Ph.D.

Lab Thread

Gender Bias AI

Testing and Correcting Gender Bias in Healthcare AI

David Alvaro, Ph.D.

Pharma's Almanac

Data Integrity

Data Integrity: Drivers, Challenges, and Key Program Elements

Cynthia A. Challener, Ph.D.

Pharma's Almanac

CRO Partnerships

Building Resilient Development Models: How Mid-Size Pharma Can Scale Without Losing Control

Brian Healey

IQVIA

CNS Clinical

Insilico Completes First-in-Human Dosing in Phase I Clinical Study of AI-Driven NLRP3 Inhibitor ISM8969

Insilico Medicine

Clinical Evidence

Rethinking Clinical Evidence Requirements in Rare Diseases

David Alvaro, Ph.D.

Pharma's Almanac

Digital Sampling

Enhancing Quality and Environmental Monitoring Efficiency Through Paperless Sampling

Jiwoon Kim; Neulbit Kim; Hyeonjung Park

Samsung Biologics

Protein Engineering

Exponential Advances in Protein Engineering

Cynthia A. Challener, Ph.D.

Pharma's Almanac

AI in Manufacturing

Validating and Governing AI in GMP Manufacturing

Pharma's Almanac

AI Data Integrity

Data Integrity in the Age of AI-Assisted Manufacturing

Pharma's Almanac

Partnership

The Solubility Company and Persist AI Unveil Strategic Partnership to Bridge the Data Gap in AI-Driven Drug Formulation

The Solubility Company

Related Content

AI-Optimized CLD

From Screening to Design: Can Production Cell Lines Become Programmable Platforms?

David Alvaro, Ph.D.

Pharma's Almanac

Preclinical R&D

How Much of Your Last Year’s Research Budget Felt Wasted? The Hidden Cost of Experimental Inconsistencies

Sophie Lutter, Ph.D.; Andrew Chalmers, Ph.D.

Lab Thread

Gender Bias AI

Testing and Correcting Gender Bias in Healthcare AI

David Alvaro, Ph.D.

Pharma's Almanac

Data Integrity

Data Integrity: Drivers, Challenges, and Key Program Elements

Cynthia A. Challener, Ph.D.

Pharma's Almanac

CRO Partnerships

Building Resilient Development Models: How Mid-Size Pharma Can Scale Without Losing Control

Brian Healey

IQVIA

CNS Clinical

Insilico Completes First-in-Human Dosing in Phase I Clinical Study of AI-Driven NLRP3 Inhibitor ISM8969

Insilico Medicine

Clinical Evidence

Rethinking Clinical Evidence Requirements in Rare Diseases

David Alvaro, Ph.D.

Pharma's Almanac

Digital Sampling

Enhancing Quality and Environmental Monitoring Efficiency Through Paperless Sampling

Jiwoon Kim; Neulbit Kim; Hyeonjung Park

Samsung Biologics